Literature DB >> 17339660

Reassessing how society prioritizes the health of young people.

Daniel Eisenberg1, Gary L Freed.   

Abstract

A number of important health policy issues, such as the allocation of flu vaccines during a pandemic, require society to determine priorities across different age groups. Cost-effectiveness analysis (CEA) and related methods of economic evaluation are often useful for determining optimal resource allocations. Using the examples of recently evaluated vaccine interventions, we show that current methods of CEA are likely to under-value health interventions for young people, relative to societal preferences inferred from research on age preferences and the value of health over time. These findings demonstrate important considerations regarding how society distributes health resources across age groups.

Entities:  

Mesh:

Year:  2007        PMID: 17339660     DOI: 10.1377/hlthaff.26.2.345

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  4 in total

1.  Characteristics and quality of pediatric cost-utility analyses.

Authors:  Seija K Kromm; Jennifer Bethell; Ferne Kraglund; Sarah A Edwards; Audrey Laporte; Peter C Coyte; Wendy J Ungar
Journal:  Qual Life Res       Date:  2011-10-29       Impact factor: 4.147

Review 2.  Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice.

Authors:  Christopher H Wade; Beth A Tarini; Benjamin S Wilfond
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-07-15       Impact factor: 8.929

3.  Community-based values for 2009 pandemic influenza A H1N1 illnesses and vaccination-related adverse events.

Authors:  Tara A Lavelle; Martin I Meltzer; Achamyeleh Gebremariam; Kara Lamarand; Anthony E Fiore; Lisa A Prosser
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

4.  Does it matter whose opinion we seek regarding the allocation of healthcare resources? - a case study.

Authors:  K Kolasa; T Lewandowski
Journal:  BMC Health Serv Res       Date:  2015-12-18       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.